Novel Therapy with Intravesical Liposomes for Ulcerative Interstitial Cystitis/Painful Bladder Syndrome

LUTS: Lower Urinary Tract Symptoms

Volumn 4, Issue 1, 2012, Pages 51-53

  Peters, Kenneth M ^a   Hasenau, Deborah L ^a   Anthony, Michele ^b   Kaufman, Jonathan ^b   Killinger, Kim A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Lipella Pharmaceuticals Inc   (United States)

Author keywords

Interstitial cystitis; Intravesical instillation; Liposomes; Urinary bladder

Indexed keywords

LIPOSOME;

ADULT; ARTICLE; BLADDER CAPACITY; BLADDER DISTENSION; CASE REPORT; CYSTALGIA; CYSTOSCOPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HEMATURIA; HUMAN; INTERSTITIAL CYSTITIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT ASSESSMENT; PATIENT MONITORING; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; QUALITY OF LIFE; UNSPECIFIED SIDE EFFECT; URINARY FREQUENCY; URINARY URGENCY;

EID: 84855420853     PISSN: 17575664     EISSN: 17575672     Source Type: Journal    
DOI: 10.1111/j.1757-5672.2011.00108.x     Document Type: Article

References (11)

1. Gregoriadis G. The carrier potential of liposomes in biology and medicine. N Engl J Med 1976; 295: 704-10.
2. Mayhew E, Lazo R, Vail WJ, King J, Green AM. Characterization of liposomes prepared using a microemulsifier. Biochim Biophys Acta 1984; 775: 169-74.
3. Barnadas-Rodriguez R, Sabes M. Factors involved in the production of liposomes with a high-pressure homogenizer. Int J Pharm 2001; 213: 175-86.
4. Minko T, Pakunlu RI, Wang Y, Khandare JJ, Saad M. New generation of liposomal drugs for cancer. Anticancer Agents Med Chem 2006; 6: 537-52.
5. Tyagi P, Chancellor MB, Li Z et al. Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes. J Urol 2004; 171: 483-9.
6. O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49(Suppl 5A): 58-63.
7. Melchior D, Packer CS, Johnson TC, Kaefer M. Dimethyl sulfoxide: does it change the functional properties of the bladder wall? J Urol 2003; 170: 253-8.
8. Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosan polysulphate for the treatment of interstitial cystitis. Br J Urol 1997; 79: 168-71.
9. Fraser MO, Chuang YC, Tyagi P et al. Intravesical liposome administration-a novel treatment for hyperactive bladder in the rat. Urology 2003; 61: 656-63.
10. Chuang YC, Chancellor MB, Seki S et al. Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity. Urology 2003; 61: 664-70.
11. Chuang YC, Lee WC, Lee WC, Chiang PH. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol 2009; 182: 1393-400.